Clinical utility in maximizing CD34+ cell count in stem cell grafts

被引：13
作者：
Burt, RK [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60612 USA
来源：
STEM CELLS | 1999年 / 17卷 / 06期
关键词：
D O I：
10.1002/stem.170373
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：373 / 376
页数：4
相关论文
共 22 条
  • [1] Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    Aversa, F
    Tabilio, A
    Velardi, A
    Cunningham, I
    Terenzi, A
    Falzetti, F
    Ruggeri, L
    Barbabietola, G
    Aristei, C
    Latini, P
    Reisner, Y
    Martelli, MF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) : 1186 - 1193
  • [2] MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE
    BACHARLUSTIG, E
    RACHAMIM, N
    LI, HW
    LAN, FS
    REISNER, Y
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1268 - 1273
  • [3] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
    BENSINGER, WI
    WEAVER, CH
    APPELBAUM, FR
    ROWLEY, S
    DEMIRER, T
    SANDERS, J
    STORB, R
    BUCKNER, CD
    [J]. BLOOD, 1995, 85 (06) : 1655 - 1658
  • [4] Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
    Bensinger, WI
    Clift, R
    Martin, P
    Appelbaum, FR
    Demirer, T
    Gooley, T
    Lilleby, K
    Rowley, S
    Sanders, J
    Storb, R
    Buckner, CD
    [J]. BLOOD, 1996, 88 (07) : 2794 - 2800
  • [5] HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP
    BROWN, RA
    WOLFF, SN
    FAY, JW
    PINEIRO, L
    COLLINS, RH
    LYNCH, JP
    STEVENS, D
    GREER, J
    HERZIG, RH
    HERZIG, GP
    [J]. BLOOD, 1995, 85 (05) : 1391 - 1395
  • [6] Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells
    Burt, RK
    Kuzel, TM
    Fishman, M
    Brush, M
    Villa, M
    Welles, C
    Rosen, S
    Traynor, AE
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (04) : 381 - 386
  • [7] SUBSETS OF CD34(+) CELLS AND RAPID HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
    DERCKSEN, MW
    RODENHUIS, S
    DIRKSON, MKA
    SCHAASBERG, WP
    BAARS, JW
    VANDERWALL, E
    SLAPERCORTENBACH, ICM
    PINEDO, HM
    VONDEMBORNE, AEGK
    VANDERSCHOOT, CE
    GERRITSEN, WR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1922 - 1932
  • [8] Relationship of CD34(+) cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
    Kiss, JE
    Rybka, WB
    Winkelstein, A
    deMagalhaesSilverman, M
    Lister, J
    DAndrea, P
    Ball, ED
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (04) : 303 - 310
  • [9] ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS
    KORBLING, M
    PRZEPIORKA, D
    HUH, YO
    ENGEL, H
    VANBESIEN, K
    GIRALT, S
    ANDERSSON, B
    KLEINE, HD
    SEONG, D
    DEISSEROTH, AB
    ANDREEFF, M
    CHAMPLIN, R
    [J]. BLOOD, 1995, 85 (06) : 1659 - 1665
  • [10] KORBLING M, 1997, BONE MARROW TRANS S1, V19, pS72
123